Internal Medicine, Hematology · Portland, OR
NPI
1801801311
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3181 SW Sam Jackson Park Rd
Portland, OR, 97239
Phone (503) 494-6594
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
933 services
Medicare patients, 2024
173
Average age 72
Drug cost, 2024
$1.1M
873 prescriptions
Company payments, 2025
$296
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Craig Y Okada was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 309 times for 128 patients. In total Craig Y Okada billed 933 services in 17 codes, and Medicare paid $54K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 309 | 128 | $12.73 | $3,935 |
| 99214 Office E&M - Established | Facility | 234 | 94 | $74.10 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 138 | 30 | $93.44 | $13K |
| 99213 Office E&M - Established | Facility | 73 | 53 | $46.45 | $3,391 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 29 | 19 | $13.11 | $380 |
| 99223 Hospital E&M - Initial | Facility | 25 | 16 | $136.38 | $3,410 |
| 99215 Office E&M - Established | Facility | 22 | 17 | $114.35 | $2,516 |
| 99214 Office E&M - Established | Office | 21 | 17 | $91.83 | $1,929 |
| 99213 Office E&M - Established | Office | 14 | 11 | $64.27 | $900 |
| 99443 Telephone Services | Office | 13 | 11 | $100.42 | $1,305 |
| 99205 Office E&M - New | Facility | 11 | 11 | $143.22 | $1,575 |
By year: 2022 $35K for 478 services; 2023 $52K for 615 services; 2024 $54K for 933 services.
Medicare prescription drug claims, 2024
In 2024, the drug Craig Y Okada prescribed most often to Medicare patients was Acyclovir, with 108 prescriptions and refills. In total Craig Y Okada wrote 873 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 108 | 147 | 33 | $1,225 |
| Prednisone Generic | 45 | 48 | 20 | $127 |
| Potassium Chloride Generic | 41 | 43 | Under 11 | $1,618 |
| Triamcinolone Acetonide Generic | 37 | 41 | 20 | $507 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 35 | 35 | Under 11 | $703 |
| Gabapentin Generic | 34 | 35 | 11 | $494 |
| Dexamethasone Generic | 33 | 37 | Under 11 | $618 |
| Furosemide Generic | 30 | 32 | Under 11 | $63.09 |
| Allopurinol Generic | 27 | 27 | 14 | $191 |
| Sertraline Hcl Generic | 26 | 26 | Under 11 | $129 |
| Brukinsa Zanubrutinib | 26 | 26 | Under 11 | $384K |
| Prochlorperazine Maleate Generic | 26 | 26 | 18 | $531 |
| Amlodipine Besylate Generic | 24 | 24 | Under 11 | $64 |
| Bexarotene Generic | 21 | 23 | Under 11 | $230K |
| Omeprazole Generic | 19 | 25 | Under 11 | $258 |
Brand drugs: 106 claims; generic drugs: 767 claims; opioid claims: 59.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Craig Y Okada $296 ($296 in general payments such as food, travel and fees) from 5 companies. The largest payer was Adc Therapeutics America, Inc. with $180.
| Company | Payments | Amount |
|---|---|---|
| Adc Therapeutics America, Inc. | 1 | $180 |
| Genmab U.S., Inc. GMAB | 1 | $116 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.